FAST NEWS: Clover Bio Gets Exclusive Rights for Imported Flu Vaccine
The latest: Clover Biopharmaceuticals Ltd. (2197.HK) said on Monday it has reached an exclusive agreement to import Adimmune Corp.’s quadrivalent seasonal influenza vaccine AdimFlu-S (QIS) to China. It added it will…
RELATED ARTICLES
-
Health Guard plans dual listing to fund HPV vaccine fight
- CHINA BULLETIN: Services, Trade Send Positive Signals
- CHINA BULLETIN: Manufacturing Déjà Vu
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
- CHINA BULLETIN: Blinken, Yellen Talk Up China Challenge
- CHINA BULLETIN: Fiscal Revenue, Land Sales Fall in April
